Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Scrutiny Of Patient Assistance Program Funding Is Rising

With patient assistant programs (PAP) regulators looking more closely into relationships between donor companies and foundations, the pharmaceutical industry will be forced to learn from significant settlements made this year. Loeb & Loeb chair of the firm's FDA regulatory & compliance practice Scott Liebman, partner Tiff Moseley,  and of counsel Eve Costopolous determine the key takeaways from heightened PAP enforcement and what it means for the future of regulation.

Click here to read the full article on the Law360 website.